Φορτώνει......
Emerging Immunotherapies for Parkinson Disease
Symptomatic treatment options for Parkinson disease have steadily improved, and individualized therapeutic approaches are becoming established for every stage of the disease. However, disease-modifying therapy with a causal approach is still unavailable. The central causative role of alpha-synuclein...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neurol Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Healthcare
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534677/ https://ncbi.nlm.nih.gov/pubmed/30539376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-018-0122-z |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|